Lymphovascular invasion is a dominant risk factor for lymph node metastasis in T2 rectal cancer

Abstract

Background and study aims Surgical resection is standard treatment of T2 rectal cancer due to risk of concomitant lymph node metastases (LNM). Local resection could potentially be an alternative to surgical treatment in a subgroup of patients with low risk of LNM. The aim of this study was to identify clinical and histopathological risk factors of LNM in T2 rectal cancer.

Patients and methods This was a retrospective registry-based population study on prospectively collected data on all patients with T2 rectal cancer undergoing surgical resection in Sweden between 2009 and 2021. Potential risk factors of LNM, including age, gender, resection margin, lymphovascular invasion (LVI), histologic grade, mucinous cancer, and perineural invasion (PNI) were analyzed using univariate and multivariate logistic regression.

Results Of 1607 patients, 343 (21%) with T2 rectal cancer had LNM. LVI (odds ratio [OR] = 4.21, P < 0.001) and age < 60 years (OR = 1.80, P < 0.001) were significant and independent risk factors. However, PNI (OR = 1.50, P = 0.15), mucinous cancer (OR = 1.14, P = 0.60), histologic grade (OR = 1.47, P = 0.07) and non-radical resection margin (OR = 1.64, P = 0.38) were not significant risk factors for LNM in multivariate analyses. The incidence of LNM was 15% in the absence of any risk factor.

Conclusions This was a large study on LNM in T2 rectal cancer which showed that LVI is the dominant risk factor. Moreover, low age constituted an independent risk factor, whereas gender, resection margin, PNI, histologic grade, and mucinous cancer were not independent risk factors of LNM. Thus, these findings may provide a useful basis for management of patients after local resection of early rectal cancer.

Keywords

Endoscopy Lower GI Tract - Colorectal cancer - Polyps / adenomas / ... - Endoscopic resection (polypectomy, ESD, EMRc, ...) - CRC screening

Publikationsverlauf

Eingereicht: 12. Januar 2024

Angenommen nach Revision: 11. Juli 2024

Artikel online veröffentlicht:
12. September 2024

• References

• 1 Beets GL, Figueiredo NL, Habr-Gama A. et al. A new paradigm for rectal cancer: Organ preservation: Introducing the International Watch & Wait Database (IWWD). Eur J Surg Oncol 2015; 41: 1562-1564
• 2 Peltrini R, Sacco M, Luglio G. et al. Local excision following chemoradiotherapy in T2-T3 rectal cancer: current status and critical appraisal. Updates Surg 2020; 72: 29-37
• 3 Rönnow CF, Arthursson V, Toth E. et al. Lymphovascular Infiltration, Not Depth of Invasion, is the Critical Risk Factor of Metastases in Early Colorectal Cancer: Retrospective Population-based Cohort Study on Prospectively Collected Data, Including Validation. Ann Surg 2022; 275: e148-e154
• 4 You YN, Hardiman KM, Bafford A. et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer. Dis Colon Rectum 2020; 63: 1191-1222
• 5 Ushigome H, Ohue M, Kitamura M. et al. Evaluation of risk factors for lymph node metastasis in T2 lower rectal cancer to perform chemoradiotherapy after local resection. Mol Clin Oncol 2020; 12: 390-394
• 6 Kobayashi H, Mochizuki H, Kato T. et al. Is total mesorectal excision always necessary for T1-T2 lower rectal cancer?. Ann Surg Oncol 2010; 17: 973-980
• 7 Ricciardi R, Madoff RD, Rothenberger DA. et al. Population-based analyses of lymph node metastases in colorectal cancer. Clin Gastroenterol Hepatol 2006; 4: 1522-1527
• 8 Chang HC, Huang SC, Chen JS. et al. Risk factors for lymph node metastasis in pT1 and pT2 rectal cancer: a single-institute experience in 943 patients and literature review. Ann Surg Oncol 2012; 19: 2477-2484
• 9 Ding PR, An X, Cao Y. et al. Depth of tumor invasion independently predicts lymph node metastasis in T2 rectal cancer. J Gastrointest Surg 2011; 15: 130-136
• 10 Hartwig M, Rosen A, Vogelsang R. et al. Risk factors for lymph node metastasis in patients with pT2 colon cancer in Denmark from 2016 to 2019-A nationwide cohort study. Colorectal Dis 2023; 25: 872-879
• 11 Ichimasa K, Nakahara K, Kudo SE. et al. Novel "resect and analysis" approach for T2 colorectal cancer with use of artificial intelligence. Gastrointest Endosc 2022; 96: 665-672.e661
• 12 Paun BC, Cassie S, MacLean AR. et al. Postoperative complications following surgery for rectal cancer. Ann Surg 2010; 251: 807-818
• 13 Kuellmer A, Mueller J, Caca K. et al. Endoscopic full-thickness resection for early colorectal cancer. Gastrointest Endosc 2019; 89: 1180-1189.e1181
• 14 Moons LMG, Bastiaansen BAJ, Richir MC. et al. Endoscopic intermuscular dissection for deep submucosal invasive cancer in the rectum: a new endoscopic approach. Endoscopy 2022; 54: 993-998
• 15 Rosén R, Nilsson E, Rahman M. et al. Accuracy of MRI in early rectal cancer: national cohort study. Br J Surg 2022; 109: 570-572
• 16 Bipat S, Glas AS, Slors FJ. et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis. Radiology 2004; 232: 773-783
• 17 Masaki T, Matsuoka H, Sugiyama M. et al. Tumor budding and evidence-based treatment of T2 rectal carcinomas. J Surg Oncol 2005; 92: 59-63
• 18 Goldstein NS, Hart J. Histologic features associated with lymph node metastasis in stage T1 and superficial T2 rectal adenocarcinomas in abdominoperineal resection specimens. Identifying a subset of patients for whom treatment with adjuvant therapy or completion abdominoperineal resection should be considered after local excision. Am J Clin Pathol 1999; 111: 51-58
• 19 Kajiwara Y, Ueno H, Hashiguchi Y. et al. Risk factors of nodal involvement in T2 colorectal cancer. Dis Colon Rectum 2010; 53: 1393-1399
• 20 Komori K, Kanemitsu Y, Ishiguro S. et al. Analysis of lymph node metastatic pattern according to the depth of in-growth in the muscularis propria in T2 rectal cancer for lateral lymph node dissection. Dig Surg 2011; 28: 352-359
• 21 Moberger P, Sköldberg F, Birgisson H. Evaluation of the Swedish Colorectal Cancer Registry: an overview of completeness, timeliness, comparability and validity. Acta Oncol 2018; 57: 1611-1621
• 22 Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 2002; 51: 130-131
• 23 Bretthauer M, Løberg M, Wieszczy P. et al. Effect of colonoscopy screening on risks of colorectal cancer and related death. N Engl J Med 2022; 387: 1547-1556
• 24 Rasheed S, Bowley DM, Aziz O. et al. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers. Colorectal Dis 2008; 10: 231-238
• 25 Yoshida N, Nakanishi M, Inoue K. et al. Pure well-differentiated adenocarcinoma is a safe factor for lymph node metastasis in T1 and t2 colorectal cancer: a pilot study. Gastroenterol Res Pract 2018; 2018: 8798405
• 26 Penninckx F, Kartheuser A, Van de Stadt J. et al. Outcome following laparoscopic and open total mesorectal excision for rectal cancer. Br J Surg 2013; 100: 1368-1375
• 27 Peltrini R, Imperatore N, Carannante F. et al. Age and comorbidities do not affect short-term outcomes after laparoscopic rectal cancer resection in elderly patients. A multi-institutional cohort study in 287 patients. Updates Surg 2021; 73: 527-537
• 28 Wallner C, Lange MM, Bonsing BA. et al. Causes of fecal and urinary incontinence after total mesorectal excision for rectal cancer based on cadaveric surgery: a study from the Cooperative Clinical Investigators of the Dutch total mesorectal excision trial. J Clin Oncol 2008; 26: 4466-4472
• 29 Detering R, van Oostendorp SE, Meyer VM. et al. MRI cT1–2 rectal cancer staging accuracy: a population-based study. Br J Surg 2020; 107: 1372-1382
• 30 Beets-Tan RGH, Lambregts DMJ, Maas M. et al. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 2018; 28: 1465-1475
• 31 Yamashita K, Oka S, Tanaka S. et al. Preceding endoscopic submucosal dissection for T1 colorectal carcinoma does not affect the prognosis of patients who underwent additional surgery: a large multicenter propensity score-matched analysis. J Gastroenterol 2019; 54: 897-906
• 32 Tamaru Y, Oka S, Tanaka S. et al. Long-term outcomes after treatment for T1 colorectal carcinoma: a multicenter retrospective cohort study of Hiroshima GI Endoscopy Research Group. J Gastroenterol 2017; 52: 1169-1179
• 33 Asayama N, Oka S, Tanaka S. et al. Long-term outcomes after treatment for T1 colorectal carcinoma. Int J Colorectal Dis 2016; 31: 571-578
• 34 Tong LL, Gao P, Wang ZN. et al. Is pT2 subclassification feasible to predict patient outcome in colorectal cancer?. Ann Surg Oncol 2011; 18: 1389-1396
• 35 Huh JW, Kim HR, Kim YJ. Lymphovascular or perineural invasion may predict lymph node metastasis in patients with T1 and T2 colorectal cancer. J Gastrointest Surg 2010; 14: 1074-1080
• 36 Sitzler PJ, Seow-Choen F, Ho YH. et al. Lymph node involvement and tumor depth in rectal cancers: an analysis of 805 patients. Dis Colon Rectum 1997; 40: 1472-1476
• 37 Suh JH, Han KS, Kim BC. et al. Predictors for lymph node metastasis in T1 colorectal cancer. Endoscopy 2012; 44: 590-595
• 38 Zwager LW, Bastiaansen BAJ, Montazeri NSM. et al. Deep submucosal invasion is not an independent risk factor for lymph node metastasis in T1 colorectal cancer: a meta-analysis. Gastroenterology 2022; 163: 174-189